Erytheem Roodheid
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Woman diagnosed with breastcancer which have undergone breast saving therapie 2.Radiation according to the "new" method from 21 treatments. 3.WHO-performace status 0-2 4.Skintyp according to Fitzgerald 1-4 5.Gave their permission
Exclusion criteria
Exclusion criteria: 1.Patientgroup shouldn't be treated or being treated with chemotherapy 2.No radiotherpy in the past 3.No hypertrofia / keloidal scarring 4.No metastases 5.No diabetes mellitus type 1&2 6.No illness which can influence the skinrecovery 7.No medication which couse hypersensibility from the skin 8.No hypersensitivity for one of the ingredients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Group sample sizes of 15 in both groups to achieve 93% power to detect a difference of 10,0 between the null hypothesis that both group means are 45,0 and the alternative hypothesis that the mean of group 2 is 35,0 with estimated group standard deviations of 8,0 and 8,0 and with a significance level (alpha) of 0,05 using a two-sided two-sample t-test. | — |
Secondary
| Measure | Time frame |
|---|---|
| nvt | — |
Countries
Netherlands